CRISPR/Cas9 Epigenome Editing Potential for Rare Imprinting Diseases: A Review
Imprinting diseases (IDs) are rare congenital disorders caused by aberrant dosages of imprinted genes. Rare IDs are comprised by a group of several distinct disorders that share a great deal of homology in terms of genetic etiologies and symptoms. Disruption of genetic or epigenetic mechanisms can c...
Main Authors: | Linn Amanda Syding, Petr Nickl, Petr Kasparek, Radislav Sedlacek |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/4/993 |
Similar Items
-
Deciphering Plant Chromatin Regulation via CRISPR/dCas9-Based Epigenome Engineering
by: Annick Dubois, et al.
Published: (2021-08-01) -
Concurrent genome and epigenome editing by CRISPR-mediated sequence replacement
by: Jes Alexander, et al.
Published: (2019-11-01) -
Therapeutic Editing of the <i>TP53</i> Gene: Is CRISPR/Cas9 an Option?
by: Regina Mirgayazova, et al.
Published: (2020-06-01) -
Entering the post-epigenomic age: back to epigenetics
by: Sebastian Bultmann, et al.
Published: (2018-03-01) -
Various Aspects of a Gene Editing System—CRISPR–Cas9
by: Edyta Janik, et al.
Published: (2020-12-01)